Literature DB >> 17827022

Novel, potent THC/anandamide (hybrid) analogs.

Caryl Bourne1, Sucharita Roy, Jenny L Wiley, Billy R Martin, Brian F Thomas, Anu Mahadevan, Raj K Razdan.   

Abstract

The structure-activity relationship (SAR) of the end pentyl chain in anandamide (AEA) has been established to be very similar to that of Delta(9)-tetrahydrocannabinol (Delta(9)-THC). In order to broaden our understanding of the structural similarities between AEA and THC, hybrid structures 1-3 were designed. In these hybrids the aromatic ring of THC-DMH was linked to the AEA moiety through an ether linkage with the oxygen of the phenol of THC. Hybrid 1 (O-2220) was found to have very high binding affinity to CB1 receptors (K(i)=8.5 nM), and it is interesting to note that the orientation of the side chain with respect to the oxygen in the phenol is the same as in THCs. To further explore the SAR in this series the terminal carbon of the side chain was modified by adding different substituents. Several such analogs were synthesized and tested for their CB1 and CB2 binding affinities and in vivo activity (tetrad tests). The details of the synthesis and the biological activity of these compounds are described.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827022      PMCID: PMC2112747          DOI: 10.1016/j.bmc.2007.08.039

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  31 in total

1.  Preparation of a cis-isoprostane synthon.

Authors:  D F Taber; J H Green; W Zhang; R Song
Journal:  J Org Chem       Date:  2000-08-25       Impact factor: 4.354

Review 2.  Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

Authors:  S Agurell; M Halldin; J E Lindgren; A Ohlsson; M Widman; H Gillespie; L Hollister
Journal:  Pharmacol Rev       Date:  1986-03       Impact factor: 25.468

3.  Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

Authors:  Z Vogel; J Barg; R Levy; D Saya; E Heldman; R Mechoulam
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

4.  2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

Authors:  L Hanus; S Abu-Lafi; E Fride; A Breuer; Z Vogel; D E Shalev; I Kustanovich; R Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

5.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

6.  Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor.

Authors:  Judy Barnett-Norris; Dow P Hurst; Diane L Lynch; Frank Guarnieri; Alex Makriyannis; Patricia H Reggio
Journal:  J Med Chem       Date:  2002-08-15       Impact factor: 7.446

7.  (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

Authors:  V Abadji; S Lin; G Taha; G Griffin; L A Stevenson; R G Pertwee; A Makriyannis
Journal:  J Med Chem       Date:  1994-06-10       Impact factor: 7.446

8.  Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

Authors:  E Fride; R Mechoulam
Journal:  Eur J Pharmacol       Date:  1993-02-09       Impact factor: 4.432

9.  Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC.

Authors:  B R Martin; D R Compton; S F Semus; S Lin; G Marciniak; J Grzybowska; A Charalambous; A Makriyannis
Journal:  Pharmacol Biochem Behav       Date:  1993-10       Impact factor: 3.533

10.  Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

Authors:  J N Crawley; R L Corwin; J K Robinson; C C Felder; W A Devane; J Axelrod
Journal:  Pharmacol Biochem Behav       Date:  1993-12       Impact factor: 3.533

View more
  3 in total

1.  Design and synthesis of (13S)-methyl-substituted arachidonic acid analogues: templates for novel endocannabinoids.

Authors:  Demetris P Papahatjis; Victoria R Nahmias; Spyros P Nikas; Marion Schimpgen; Alexandros Makriyannis
Journal:  Chemistry       Date:  2010-04-06       Impact factor: 5.236

2.  N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase.

Authors:  James J Burston; Laura J Sim-Selley; John P Harloe; Anu Mahadevan; Raj K Razdan; Dana E Selley; Jenny L Wiley
Journal:  J Pharmacol Exp Ther       Date:  2008-08-05       Impact factor: 4.030

3.  A visible-light mediated ring opening reaction of alkylidenecyclopropanes for the generation of homopropargyl radicals.

Authors:  Xiao-Yu Zhang; Chao Ning; Ben Mao; Yin Wei; Min Shi
Journal:  Chem Sci       Date:  2021-05-28       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.